Rekvina Laboratories Ltd (BSE: 526075) is a Vadodara, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹79 Cr, it ranks #3,426 by market cap among the 6,197 Indian listed companies on FinBizNet, and #19 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹72.62 (as of 16 Nov 2026), the share price is 0.0% below its 52-week high of ₹72.62 and 1513.8% above its 52-week low of ₹4.50. The share price is up 1513.8% over one year and up 104.5% over three months.
| Current Price | ₹72.62 |
|---|---|
| Market Cap | ₹79 Cr |
| BSE Code | 526075 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | Not meaningful (loss) |
| Return on Assets | -26.07% |
| 52-Week Range | ₹4.50 – ₹72.62 |
| 1-Year Price Change | +1513.8% |
| 3-Month Price Change | +104.5% |
| Beta (1Y) | 0.45 |
| Headquarters | Vadodara, Gujarat |
| Website | www.rekvinalaboratories.com |
Delivery averaged 100.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Rekvina Laboratories Limited engages in manufacturing and marketing pharmaceutical products in India. It offers pharmaceutical formulations. The company also provides contract research and manufacturing services. Rekvina Laboratories Limited was incorporated in 1988 and is based in Vadodara, India.
1. Pharmaceuticals-This segment manufactures and markets pharmaceutical formulations. 2. NA-NA 3. NA-NA 4. NA-NA
1. Pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,79,494 Cr | 73.6 | 16.98% | ₹4,979 Cr | +30.4% |
| Aether Industries Limited | ₹21,710 Cr | 101.8 | 9.81% | ₹347 Cr | +127.8% |
| Alivus Life Sciences Ltd | ₹17,862 Cr | 31.5 | 18.36% | ₹682 Cr | +64.0% |
| Aarti Pharmalabs Ltd | ₹8,374 Cr | 52.5 | 8.49% | ₹610 Cr | +15.4% |
| Solara Active Pharma Sciences Limited | ₹3,225 Cr | n/m | -0.63% | ₹417 Cr | +22.1% |
| Sai Parenteral's Limited | ₹2,235 Cr | 115.8 | 2.88% | ₹195 Cr | — |
| KRM Ayurveda Limited | ₹521 Cr | 25.9 | 17.54% | ₹32 Cr | — |
| Trident Lifeline Limited | ₹511 Cr | 26 | — | — | +37.6% |
| Rekvina Laboratories Ltd | ₹79 Cr | n/m | — | — | +1513.8% |
Listed by market capitalisation. Ratios are shown for context only.
Rekvina Laboratories Ltd is trading at ₹72.62, with a market capitalisation of ₹79 Cr.
Rekvina Laboratories Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Rekvina Laboratories Ltd is listed on the BSE under the scrip code 526075.
Rekvina Laboratories Ltd's share price is up 1513.8% over one year and up 104.5% over three months. Its 52-week range is ₹4.50 to ₹72.62.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.